You just read:

Stainwei Granted US Patent for anti-VEGF Monoclonal Antibody and its anti-PD-1 mAb demonstrating prolonged anti-tumor activity in pre-clinical studies

News provided by

Stainwei

May 03, 2017, 06:00 ET